Evolution Wealth Advisors, LLC Neurocrine Biosciences Inc Transaction History

Evolution Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$79.65 - $106.22 $13,779 - $18,376	-173 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$86.18 - $99.03 $19,907 - $22,875	-231 Reduced 57.18%	173 $17,000
Q1 2021 Apr 20, 2021	SELL	$87.57 - $119.4 $2,014 - $2,746	-23 Reduced 5.39%	404 $39,000
Q4 2020 Feb 02, 2021	BUY	$86.91 - $108.33 $3,302 - $4,116	38 Added 9.77%	427 $41,000
Q3 2020 Oct 15, 2020	BUY	$96.16 - $135.15 $384 - $540	4 Added 1.04%	389 $37,000
Q2 2020 Jul 27, 2020	SELL	$85.09 - $130.36 $10,210 - $15,643	-120 Reduced 23.76%	385 $47,000
Q1 2020 Apr 22, 2020	BUY	$75.11 - $113.76 $9,463 - $14,333	126 Added 33.25%	505 $44,000
Q4 2019 Feb 03, 2020	BUY	$86.8 - $118.57 $29,512 - $40,313	340 Added 871.79%	379 $41,000
Q3 2019 Nov 12, 2019	SELL	$83.82 - $101.5 $36,629 - $44,355	-437 Reduced 91.81%	39 $4,000
Q2 2019 Jul 12, 2019	BUY	$72.24 - $91.27 $34,386 - $43,444	476 New	476 $40,000

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.